Skip to content
lifestyle.chroniccities.us
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Ocugen
Ocugen to Participate in Upcoming May Scientific and Investor Conferences
May 13, 2026
Ocugen Provides Business Update with First Quarter 2026 Financial Results
May 5, 2026
Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes
May 5, 2026
Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes
May 4, 2026
Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results
April 29, 2026
Ocugen to Present at April 2026 Investor and Industry Conferences
April 23, 2026
Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease
April 1, 2026
Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa
March 2, 2026
Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer
February 12, 2026
←
Previous Page
1
2